Restoring expression of Stathmin-2: a novel strategy to treat TDP-43 proteinopathies.
作者信息
Menge Sonja, Decker Lorena, Freischmidt Axel
机构信息
Department of Neurology, Ulm University, 89081, Ulm, Germany.
出版信息
Signal Transduct Target Ther. 2023 Jul 12;8(1):266. doi: 10.1038/s41392-023-01533-1.
Abstract
摘要
相似文献
1
Restoring expression of Stathmin-2: a novel strategy to treat TDP-43 proteinopathies.恢复Stathmin-2的表达：一种治疗TDP-43蛋白病的新策略。
Signal Transduct Target Ther. 2023 Jul 12;8(1):266. doi: 10.1038/s41392-023-01533-1.
2
Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration.Stathmin-2：为 TDP-43 蛋白病和神经退行性变的谜题再添一块。
J Clin Invest. 2020 Nov 2;130(11):5677-5680. doi: 10.1172/JCI142854.
3
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.TDP-43 蛋白病变中涉及的 TDP-43 功能和致病机制。
Trends Mol Med. 2011 Nov;17(11):659-67. doi: 10.1016/j.molmed.2011.06.004. Epub 2011 Jul 23.
4
Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy.tau 和 TDP-43 蛋白病：亲缘病理级联和遗传多效性。
Lab Invest. 2019 Jul;99(7):993-1007. doi: 10.1038/s41374-019-0196-y. Epub 2019 Feb 11.
5
[TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].[TDP-43蛋白病：对分子发病机制的理解]
Rinsho Shinkeigaku. 2009 Nov;49(11):783-5. doi: 10.5692/clinicalneurol.49.783.
6
Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.TDP-43蛋白病条件性小鼠模型中的可逆行为表型。
J Neurosci. 2014 Nov 12;34(46):15244-59. doi: 10.1523/JNEUROSCI.1918-14.2014.
7
Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.神经病理学标志性蛋白TDP-43的代谢与代谢异常
J Cell Sci. 2014 Jul 15;127(Pt 14):3024-38. doi: 10.1242/jcs.136150. Epub 2014 May 23.
8
Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.泛素化、p62 免疫阳性的小脑皮质神经元包含物在 TDP-43 蛋白病谱中均可见，但仅偶尔对磷酸化依赖的 TDP-43 也呈免疫阳性。
Neuropathology. 2011 Jun;31(3):239-49. doi: 10.1111/j.1440-1789.2010.01171.x. Epub 2010 Dec 1.
9
HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.组蛋白去乙酰化酶 1 失调诱导 TDP-43 蛋白病进展中的细胞周期异常和 DNA 损伤。
EMBO Mol Med. 2020 Jun 8;12(6):e10622. doi: 10.15252/emmm.201910622. Epub 2020 May 25.
10
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.过早的多聚腺苷酸化介导 stathmin-2 的缺失是 TDP-43 依赖性神经退行性变的一个标志。
Nat Neurosci. 2019 Feb;22(2):180-190. doi: 10.1038/s41593-018-0293-z. Epub 2019 Jan 14.
引用本文的文献
1
Inhibition of SOD1 trimerization is a novel drug target for ALS disease.抑制超氧化物歧化酶1（SOD1）三聚化是肌萎缩侧索硬化症（ALS）疾病的一个新的药物靶点。
Transl Neurodegener. 2025 May 12;14(1):21. doi: 10.1186/s40035-025-00483-8.
2
Genomic tumor evolution dictates human medulloblastoma progression.基因组肿瘤进化决定人类髓母细胞瘤的进展。
Neurooncol Adv. 2024 Oct 5;6(1):vdae172. doi: 10.1093/noajnl/vdae172. eCollection 2024 Jan-Dec.
本文引用的文献
1
Mechanism of cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies.隐匿剪接多聚腺苷酸化的机制及其在 TDP-43 蛋白病中的纠正作用。
Science. 2023 Mar 17;379(6637):1140-1149. doi: 10.1126/science.abq5622. Epub 2023 Mar 16.
2
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.TDP-43 失调与肌萎缩侧索硬化症中的运动神经元-肌肉接头破坏。
Transl Neurodegener. 2022 Dec 27;11(1):56. doi: 10.1186/s40035-022-00331-z.
3
Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy.TDP-43 相关肌萎缩侧索硬化症的标志性蛋白 Stathmin-2 的缺失可导致运动性神经病。
Cell Rep. 2022 Jun 28;39(13):111001. doi: 10.1016/j.celrep.2022.111001.
4
Loss of mouse Stmn2 function causes motor neuropathy.Stmn2 功能缺失导致小鼠运动神经病。
Neuron. 2022 May 18;110(10):1671-1688.e6. doi: 10.1016/j.neuron.2022.02.011. Epub 2022 Mar 15.
5
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.过早的多聚腺苷酸化介导 stathmin-2 的缺失是 TDP-43 依赖性神经退行性变的一个标志。
Nat Neurosci. 2019 Feb;22(2):180-190. doi: 10.1038/s41593-018-0293-z. Epub 2019 Jan 14.
Zotero 插件